Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients

Molecular Vision

Volumn 12, Issue , 2006, Pages 1601-1605

  Horie, Yukihiro ^a   Takemoto, Yuko ^a   Miyazaki, Akiko ^a   Namba, Kenichi ^a   Kase, Satoru ^a   Yoshida, Kazuhiko ^a   Ota, Masao ^b   Hasumi, Yukiko ^c   Inoko, Hidetoshi ^d   Mizuki, Nobuhisa ^c   Ohno, Shigeaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPACHROME TAUTOMERASE; GENOMIC DNA; HLA DR ANTIGEN; MONOPHENOL MONOOXYGENASE; TYROSINASE RELATED PROTEIN 1;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA TYPING; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS; VOGT KOYANAGI SYNDROME;

ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOME MAPPING; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MEMBRANE GLYCOPROTEINS; MICROSATELLITE REPEATS; MONOPHENOL MONOOXYGENASE; MULTIGENE FAMILY; OXIDOREDUCTASES; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 33846024381     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Read RW, Rao NA, Cunningham ET. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol 2000; 11:437-42.
2. Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 1994; 78:223-6.
3. Islam SM, Numaga J, Fujino Y, Hirata R, Matsuki K, Maeda H, Masuda K. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol. Vis Sci 1994; 35:3890-6.
4. Shindo Y, Ohno S, Usui M, Ideta H, Harada K, Masuda H, Inoko H. Immunogenetic study of sympathetic ophthalmia. Tissue Antigens 1997; 49:111-5.
5. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviate C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423:506-11.
6. Carlton VE, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC, Chang M, Catanese JJ, Leong DU, Ardlie KG, Kastner DL, Seldin MF, Criswell LA, Gregersen PK, Beasley E, Thomson G, Amos CI, Begovich AB. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005; 77:567-81.
7. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdottir H, Grondal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, Jonssen A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcon-Segovia D, Steinsson K, Alarcon-Riquelme ME. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32:666-9.
8. Yamaki K, Kondo I, Nakamura H, Miyano M, Konno S, Sakuragi S. Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res 2000;71:361-9.
9. Yamaki K, Takiyama N, Itho N, Mizuki N, Seiya M, Sinsuke W, Hayakawa K, Kotani T. Experimentally induced Vogt-Koyanagi-Harada disease in two Akita dogs. Exp Eye Res 2005; 80:273-80.
10. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 2000; 165:7323-9.
11. Tamiya G, Shinya M, Imanishi T, Ikuta T, Makino S, Okamoto K, Furugaki K, Matsumoto T, Mano S, Ando S, Nozaki Y, Yukawa W, Nakashige R, Yamaguchi D, Ishibashi H, Yonekura M, Nakami Y, Takayama S, Endo T, Saruwatari T, Yagura M, Yoshikawa Y, Fujimoto K, Oka A, Chiku S, Linsen SE, Giphart MJ, Kulski JK, Fukazawa T, Hashimoto H, Kimura M, Hoshina Y, Suzuki Y, Hotta T, Mochida J, Minezaki T, Komai K, Shiozawa S, Taniguchi A, Yamanaka H, Kamatani N, Gojobori T, Bahram S, Inoko H. Whole genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum Mol Genet 2005; 14:2305-21.
12. Ohashi J, Tokunaga K. Power of genome-wide linkage disequilibrium testing by using microsatellite markers. J Hum Genet 2003; 48:487-91.
13. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001; 131:647-52.
14. Sturm RA, Teasdale RD, Box NF. Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 2001; 277:49-62.
15. Ota M, Seki T, Fukushima H, Tsuji K, Inoko H. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-speific primers. Tissue Antigens 1992; 39:187-202.
16. Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, Schork NJ. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 2001; 11: 143-51.
17. Jimenez-Cervantes C, Solano F, Kobayashi T, Urabe K, Hearing VJ, Lozano JA, Garcia-Borron JC. A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). J Biol Chem 1994; 269:17993-8000.
18. Jimbow K. Current update and trends in melanin pigmentation and melanin biology. Keio J Med 1995; 44:9-18.
19. Oetting WS. The tyrosinase gene and oculocutaneous. albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation. Pigment Cell Res 2000; 13:320-5.
20. Sundaresan P, Sil AK, Philp AR, Randolph MA, Natchiar G, Namperumalsamy P, Genetic analysis of oculocutaneous albinism type 1 (OCA1) in Indian families: two novel frameshift mutations in the TYR Gene. Mol Vis 2004; 10: 1005- 10.
21. Chaki M, Mukhopadhyay A, Chatterjee S, Das M, Samanta. S, Ray K. Higher prevalence of OCA1 in an ethnic group of eastern India is due to a founder mutation in the tyrosinase gene. Mol Vis 2005; 11:531-4.
22. Burdon KP, Wilkinson RM, Barbour JM, Dickinson JL, Stankovich JM, Mackey DA, Sale MM. Investigation of albinism genes in congenital esotropia. Mol Vis 2003; 9:710-4.
23. Ramprasad VL, Sripriya S, Ronnie G, Nancarrow D, Saxena S, Hemamalini A, Kumar D, Vijaya L, Kumaramanickavel G. Genetic homogeneity for inherited congenital microcoria loci in an Asian Indian pedigree. Mol Vis 2005; 11:934-40.
24. Oetting WS, King RA. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat 1999; 13:99-115.
25. Schnur RE, Sellinger BT, Holmes SA, Wick PA, Tatsumura YO, Spritz RA. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinas.e gene. J Invest Dermatol 1996; 106:1137-40.
26. Eisenberg R. Mechanisms of autoimmunity. Immunol Res 2003; 27:203-18.
27. Moots RJ. A fistful of T cells. Br J Rheumatol 1998; 37:602-11.